Jayson Bedford
Stock Analyst at Raymond James
(3.94)
# 550
Out of 4,884 analysts
312
Total ratings
56.61%
Success rate
7.61%
Average return
Main Sectors:
Stocks Rated by Jayson Bedford
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PODD Insulet | Maintains: Outperform | $328 → $360 | $301.05 | +19.58% | 27 | May 27, 2025 | |
| ICUI ICU Medical | Maintains: Strong Buy | $197 → $187 | $135.07 | +38.45% | 20 | May 9, 2025 | |
| MASI Masimo | Maintains: Outperform | $204 → $185 | $167.57 | +10.40% | 7 | May 7, 2025 | |
| ZBH Zimmer Biomet Holdings | Maintains: Outperform | $119 → $104 | $93.67 | +11.03% | 8 | May 6, 2025 | |
| MMSI Merit Medical Systems | Maintains: Outperform | $116 → $108 | $93.58 | +15.41% | 27 | Apr 25, 2025 | |
| BSX Boston Scientific | Maintains: Strong Buy | $122 → $121 | $104.32 | +15.99% | 25 | Apr 24, 2025 | |
| ABT Abbott Laboratories | Maintains: Outperform | $132 → $142 | $134.44 | +5.62% | 28 | Apr 17, 2025 | |
| JNJ Johnson & Johnson | Maintains: Outperform | $162 → $164 | $156.01 | +5.12% | 23 | Apr 16, 2025 | |
| ISRG Intuitive Surgical | Maintains: Outperform | $560 → $688 | $544.47 | +26.36% | 8 | Jan 24, 2025 | |
| DXCM DexCom | Maintains: Strong Buy | $115 → $99 | $82.93 | +19.38% | 30 | Oct 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $275 → $270 | $176.16 | +53.27% | 3 | Aug 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $13 | $10.93 | +18.94% | 1 | Jul 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $12 → $10 | $9.59 | +4.33% | 14 | Jan 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $227 → $271 | $119.90 | +126.02% | 12 | Dec 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $13.24 | - | 10 | Nov 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $16.78 | - | 13 | Apr 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $76.79 | - | 20 | Feb 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $31.01 | - | 6 | Jan 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $88.39 | - | 14 | Aug 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | n/a | $0.50 | - | 4 | Mar 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $75 → $86 | $64.78 | +32.76% | 4 | Nov 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $1.30 | - | 5 | Aug 2, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $13.49 | - | 3 | Jan 2, 2018 |
Insulet
May 27, 2025
Maintains: Outperform
Price Target: $328 → $360
Current: $301.05
Upside: +19.58%
ICU Medical
May 9, 2025
Maintains: Strong Buy
Price Target: $197 → $187
Current: $135.07
Upside: +38.45%
Masimo
May 7, 2025
Maintains: Outperform
Price Target: $204 → $185
Current: $167.57
Upside: +10.40%
Zimmer Biomet Holdings
May 6, 2025
Maintains: Outperform
Price Target: $119 → $104
Current: $93.67
Upside: +11.03%
Merit Medical Systems
Apr 25, 2025
Maintains: Outperform
Price Target: $116 → $108
Current: $93.58
Upside: +15.41%
Boston Scientific
Apr 24, 2025
Maintains: Strong Buy
Price Target: $122 → $121
Current: $104.32
Upside: +15.99%
Abbott Laboratories
Apr 17, 2025
Maintains: Outperform
Price Target: $132 → $142
Current: $134.44
Upside: +5.62%
Johnson & Johnson
Apr 16, 2025
Maintains: Outperform
Price Target: $162 → $164
Current: $156.01
Upside: +5.12%
Intuitive Surgical
Jan 24, 2025
Maintains: Outperform
Price Target: $560 → $688
Current: $544.47
Upside: +26.36%
DexCom
Oct 25, 2024
Maintains: Strong Buy
Price Target: $115 → $99
Current: $82.93
Upside: +19.38%
Aug 2, 2024
Maintains: Outperform
Price Target: $275 → $270
Current: $176.16
Upside: +53.27%
Jul 1, 2024
Initiates: Outperform
Price Target: $13
Current: $10.93
Upside: +18.94%
Jan 9, 2024
Maintains: Outperform
Price Target: $12 → $10
Current: $9.59
Upside: +4.33%
Dec 20, 2023
Maintains: Outperform
Price Target: $227 → $271
Current: $119.90
Upside: +126.02%
Nov 16, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $13.24
Upside: -
Apr 24, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $16.78
Upside: -
Feb 6, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $76.79
Upside: -
Jan 5, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $31.01
Upside: -
Aug 24, 2022
Downgrades: Market Perform
Price Target: n/a
Current: $88.39
Upside: -
Mar 5, 2021
Downgrades: Underperform
Price Target: n/a
Current: $0.50
Upside: -
Nov 5, 2020
Maintains: Outperform
Price Target: $75 → $86
Current: $64.78
Upside: +32.76%
Aug 2, 2019
Downgrades: Market Perform
Price Target: n/a
Current: $1.30
Upside: -
Jan 2, 2018
Downgrades: Market Perform
Price Target: n/a
Current: $13.49
Upside: -